Wells Fargo & Company »

Bicara Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Bicara Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $409k 26k 15.79
2025-06-30 $202k 22k 9.29
2025-03-31 $134k 10k 13.03
2024-12-31 $175k 10k 17.42

More positions owned by Wells Fargo & Company

Microsoft Corporation Call Option (MSFT)
Apple Put Option (AAPL)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Ishares Tr Core S&p Ttl Stk (ITOT)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds Mid Cap Etf (VO)
JPMorgan Chase & Co. Put Option (JPM)
Amazon Call Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Meta Platforms Cl A (META)

View all positions for Wells Fargo & Company

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Vestal Point Capital
Red Tree Management
Tpg Gp A
FMR
Deep Track Capital
BlackRock
Omega Fund Management
Vanguard Group
Blackstone Group
Millennium Management
Geode Capital Management
Fil
Acorn Capital Advisors

View all funds holding Bicara Therapeutics